Senate Bill 510 - A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Purpose and Summary

Chamber: Senate

Introduced date: 2023-12-14

Recent Activity

Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)

Alternative Names

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Associated Legislation

undefined

Policy Areas

Health

Potential Impact

Sponsors and Supporters

Sen. Warren, Elizabeth [D-MA]

Cosponsors and Supporters

Sen. Baldwin, Tammy [D-WI]

Sen. Blumenthal, Richard [D-CT]

Sen. Schumer, Charles E. [D-NY]

Sen. Heinrich, Martin [D-NM]

Sen. Merkley, Jeff [D-OR]

Sen. Padilla, Alex [D-CA]

Sen. Hirono, Mazie K. [D-HI]

Sen. Brown, Sherrod [D-OH]

Sen. Hickenlooper, John W. [D-CO]

Sen. Stabenow, Debbie [D-MI]

Sen. Bennet, Michael F. [D-CO]

Sen. Duckworth, Tammy [D-IL]

Sen. Cantwell, Maria [D-WA]

Sen. Shaheen, Jeanne [D-NH]

Sen. Van Hollen, Chris [D-MD]

Sen. King, Angus S., Jr. [I-ME]

Sen. Wyden, Ron [D-OR]

Sen. Fetterman, John [D-PA]

Sen. Butler, Laphonza R. [D-CA]

Sen. Reed, Jack [D-RI]

Sen. Carper, Thomas R. [D-DE]

Sen. Cortez Masto, Catherine [D-NV]

Sen. Welch, Peter [D-VT]

Sen. Rosen, Jacky [D-NV]

Sen. Murphy, Christopher [D-CT]

Sen. Sinema, Kyrsten [I-AZ]

Sen. Sanders, Bernard [I-VT]

Sen. Menendez, Robert [D-NJ]

Sen. Gillibrand, Kirsten E. [D-NY]

Sen. Smith, Tina [D-MN]

Sen. Schatz, Brian [D-HI]

Sen. Kelly, Mark [D-AZ]

Sen. Markey, Edward J. [D-MA]

Sen. Hassan, Margaret Wood [D-NH]

Sen. Whitehouse, Sheldon [D-RI]

Sen. Warnock, Raphael G. [D-GA]

Sen. Durbin, Richard J. [D-IL]

Sen. Booker, Cory A. [D-NJ]

Sen. Klobuchar, Amy [D-MN]

Sen. Ossoff, Jon [D-GA]

Sen. Murray, Patty [D-WA]

Committees and Subcommittees

Health, Education, Labor, and Pensions Committee

Variations and Revisions

Kirsten E. Gillibrand

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

1/24/2024, 10:15 PM
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Congress
118

Number
SRES - 510

Introduced on
2023-12-14

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

12/14/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Alternative Names
Official Title as IntroducedA resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Policy Areas
Health

Comments

Recent Activity

Latest Action12/14/2023
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)